The condition develops through slow, chronic blood transfer between the twins across small placental vascular anastomoses. Over time, this exchange can leave one fetus with reduced red-cell volume and the other with an excess. Because the process is gradual, the resulting anemia and polycythemia may emerge without the pronounced amniotic-fluid changes associated with other twin complications.
Middle cerebral artery peak systolic velocity, measured with Doppler ultrasound, provides an indirect assessment of fetal blood status. Increased velocity suggests anemia, whereas reduced velocity suggests polycythemia. Evaluating these opposing Doppler patterns in the two fetuses helps clinicians recognize the hematologic imbalance and distinguish it from findings based mainly on fluid-volume differences.
The main distinction is the type of surveillance finding that raises concern. TAPS may occur without marked amniotic-fluid discordance, so fluid assessment alone can miss the condition. In contrast, TAPS evaluation relies particularly on serial middle cerebral artery Doppler measurements, which identify velocity patterns suggesting anemia in one twin and polycythemia in the other.
Serial ultrasound allows clinicians to monitor changes in each twin over time rather than relying on a single examination. Repeated Doppler assessment of middle cerebral artery peak systolic velocity can reveal evolving divergence, with increasing values in one fetus and decreasing values in the other. This ongoing comparison supports earlier recognition and specialist management.
Postnatal hemoglobin assessment provides a direct check of the blood differences suspected before birth. Finding anemia in one newborn and polycythemia in the other supports the prenatal Doppler interpretation and helps confirm the diagnosis after delivery. This assessment is especially useful when prenatal findings require confirmation or when the condition was not fully characterized antenatally.
Recognition of the characteristic Doppler pattern prompts specialist monitoring and treatment planning. Clinicians can use the diagnosis to consider whether fetal intervention or delivery is indicated, based on the evolving findings and clinical circumstances. Early identification is therefore important not because it alone determines management, but because it creates time to evaluate options for the affected monochorionic pregnancy.